An update on aspirin in the primary prevention of vascular disease

被引：0
|
作者：
Eidelman, RS
Hebert, PR
Weisman, S
Hennekens, CH
机构：
[1] Mt Sinai Med Ctr, Miami Heart Inst, Miami Beach, FL 33140 USA
[2] Yale Univ, Sch Med, New Haven, CT USA
[3] Innovat Sci Solut, Morristown, NJ USA
来源：
CIRCULATION | 2002年 / 106卷 / 19期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3553
引用
收藏
页码：721 / 721
页数：1
相关论文
共 50 条
  • [11] Primary vascular prevention: The end of the road for aspirin?
    Ajjan, R. A.
    DIABETES & VASCULAR DISEASE RESEARCH, 2018, 15 (06): : 475 - 476
  • [12] Update on aspirin in the treatment and prevention of cardiovascular disease
    Hennekens, CH
    AMERICAN HEART JOURNAL, 1999, 137 (04) : S9 - S13
  • [13] Update on aspirin in the treatment and prevention of cardiovascular disease
    Hennekens, CH
    AMERICAN JOURNAL OF MANAGED CARE, 2002, 8 (22): : S691 - S700
  • [14] An overview of the 4 randomized trials of aspirin therapy in the primary prevention of vascular disease
    Hebert, PR
    Hennekens, CH
    ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (20) : 3123 - 3127
  • [15] Aspirin in the primary prevention of cardiovascular disease
    Galloway, Colin F.
    Stevenson, John C.
    MATURITAS, 2011, 68 (01) : 3 - 4
  • [16] Aspirin for primary prevention of cardiovascular disease
    Nansseu J.R.N.
    Noubiap J.J.N.
    Thrombosis Journal, 13 (1)
  • [17] Aspirin for primary prevention of cardiovascular disease
    Capodanno, Davide
    Angiolillo, Dominick J.
    LANCET, 2018, 392 (10152): : 988 - 990
  • [18] Aspirin for primary prevention of cardiovascular disease
    Waltering, A
    Hemkens, L
    Florack, C
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2005, 130 (49) : 2847 - 2852
  • [19] Aspirin for primary prevention of cardiovascular disease
    Gelbenegger, G.
    Postula, M.
    Pecen, L.
    Halvorsen, S.
    Lesiak, M.
    Schoergenhofer, C.
    Jilma, B.
    Hengstenberg, C.
    Siller-Matula, J. M.
    EUROPEAN HEART JOURNAL, 2019, 40 : 276 - 276
  • [20] Aspirin for primary prevention of cardiovascular disease
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2000, 42 (1072): : 18 - 18
12345